
    
      This study will assess the immunogenicity in infants (at birth and just prior to primary
      pertussis vaccination [i.e. diphtheria, tetanus and pertussis [DTP] vaccination] administered
      at 8 weeks of age), of a single Boostrix booster dose administered to their mothers during
      the second or third trimester as per routine practice in Bogota, Colombia.
    
  